Erman Akkus/X
Dec 22, 2024, 17:44
Erman Akkus: Local treatments of HCC, 2 recent studies
Erman Akkus, Medical Oncology fellow at Ankara University, shared a post on X:
“Local treatments of HCC, 2 recent studies.
1) SBRT vs RFA for recurrent small HCC (single lesion ≤5 cm).
- Local PFS is better with SBRT.
- PFS, OS, safety are not different.
2) SBRT followed bu sorafenib vs. sorafenib alone for locally advanced HCC unsuitable for or refractory to standard local-regional therapies
- mOS: 15.8 vs 12.3 mo.”
Erman Akkus is a medical oncology fellow at the Ankara University, Faculty of Medicine. Previously, he was an Internal Medicine Resident at the Ankara University, Faculty of Medicine. He was also a Visiting Researcher at the University of Oslo. He completed his education from the Medical University of Vienna.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 22, 2024, 17:44
Dec 22, 2024, 17:39
Dec 22, 2024, 17:36
Dec 22, 2024, 17:32
Dec 22, 2024, 17:18
Dec 22, 2024, 16:46